WHAT IS IT ABOUT?

NEW in 2023, the yearly Pfizer Oncology Award is intended to support, recognise and encourage two innovative projects in Belgium or Luxembourg that improve the quality and/or availability of patient care in oncology:
1. The “classical” Oncology Award of 20.000€ will reward a project focusing on oncology and/or hematology patient care.
2. A NEW Oncology/Covid Award of 10.000€ will reward a project focusing on oncology and/or hematology patient care, specifically associated with Covid-19.

The Pfizer Oncology & Oncology/Covid Awards are open to any project related to the clinical, surgical and medical or technical aspects of patient care in oncology and/or hematology, but also to different ways of collaboration and/or organisation between various health care providers or between levels of care during the course of the disease.

WHO IS IT FOR?

The Pfizer Oncology Award is inviting health care professionals who are linked to a hospital, a network of hospitals, a university, a certified medical centre or a registered scientific society in Belgium or Luxembourg to submit a project which meets the required criteria (for all details please go to the Rules page).
The project must aim at improving the quality and/or availability of oncology patient care in Belgium or Luxembourg.
The project may not already be in the implementation phase, but should be in a conceptual or design phase and should start within the year following the distribution of the award.
A set of rules including pre-defined selection criteria has been developed by an independent Scientific Committee who will select the winning project.

WHO IS THE JURY ?

  • PROF. SYLVIE ROTTEY, MD, PhD

    Medical Oncologist, Clinical Pharmacologist
    Head of the department  of Medical Oncology Gent University Hospital
    Head of the Drug Research Unit Gent

     

  • PROF. AHMAD AWADA, MD, PhD

    Head of the Medical Oncology
    Clinic at Jules Bordet Institute Brussels

  • DR. GUY BERCHEM MD, PhD

    Medical Oncologist, Head
    Oncology Platform Centre Hospitalier de Luxembourg (CHL) President Luxembourg National Institute of Cancer (INC)

  • MR. PATRICK CROMBEZ RN, AOCNS, MSCN, MHCM, MMCA

    Head Nurse Department
    of Hematology Bordet Institute Brussels
    President of the Belgian Oncology Nursing Society SIO
    Executive Board Member European Oncology Nursing Society

  • PROF. EM. JACQUES DE GRÈVE, MD, PhD

  • MR. SVEN D’HAESE, MSC

    Coordinator of the Radiotherapy Department of UZ Brussel
    Chairman of VVRO (Society for Radiotherapy and Oncology nurses)

  • PROF. GUY JERUSALEM, MD, PhD

    Head of Medical Oncology
    CHU Sart Tilman Liege

  • PROF. JEAN - FRANCOIS BAURAIN, MD, PhD

    Head of Clinic
    Responsible of melanoma Clinic
    Cliniques universitaires Saint-Luc – Brussels

  • PROF. DR. HANS PRENEN

    Head of Oncology department,
    Head of Phase 1 - Clinical Trials
    Universitair Ziekenhuis Antwerpen

  • PROF. ANNE DEMOLS, MD, PhD

    Department of Gastroenterology and Digestive Oncology,
    Hôpital Erasme et Institut Jules Bordet, HUB

  • PROF. PETER VANDENBERGHE, MD, PhD

    Head of Department of Haematology,
    UZ Leuven

    Department of Human Genetics,
    KU Leuven

  • DR. LORE DECOSTER, MD, PhD

    Medical Oncology
    UZ Brussel

HOW TO PARTICIPATE?

SUBMIT YOUR PROJECT
VIA THE ONLINE APPLICATION FORM

TAKE A LOOK
AT THE RULES